BridgeBio Pharma, Inc. ($BBIO)
Filing Information
| Accession Number | 0001470831-26-000182 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
30,000
Total Value
$922,056.60
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 17, 2026 | Exercise/Conversion | 10,000 | $16.75 | $167,500.00 | 21,589 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 17, 2026 | Sale | 1,900 | $74.34 | $141,249.99 | 19,689 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 17, 2026 | Sale | 4,793 | $75.57 | $362,218.99 | 14,896 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 17, 2026 | Sale | 3,307 | $75.93 | $251,087.61 | 11,589 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 17, 2026 | Exercise/Conversion | 10,000 | $0.00 | $0.00 | 31,501 | Direct | โ | View Details |